Skip to main content

Effects of Pulsed Electromagnetic Field Therapy on Outcomes Associated With Osteoarthritis: A Systematic Review of Systematic Reviews

Technology context Clinical PEMF therapy for diagnosed osteoarthritis, predominantly of the knee

Finding: Across ten systematic reviews, most concurrence was observed for short-term pain reduction, with greater variability for stiffness and physical function - but the authors state no sufficient proof of efficacy can be derived.

Main limitation: Most included reviews were of low or medium quality, treatment schemes were very heterogeneous, and sample sizes were generally low.

Executive summary

When several systematic reviews of the same evidence reach different conclusions, that disagreement is itself information. This umbrella review set out to map it.

The authors searched PubMed, Embase, PEDro and Web of Science based on a predetermined protocol. Sixty-nine studies were identified; after removing duplicates and screening title, abstract and full text, ten were included in the final analysis.

All included reviews focused on knee osteoarthritis. Four also reported on cervical, two on hand, and one on ankle osteoarthritis. In terms of level of evidence and bias, most studies were of low or medium quality.

The clearest signal was pain: most concurrence was observed for pain reduction. Other endpoints such as stiffness or physical function showed greater variability in outcomes.

The conclusion is carefully balanced and worth quoting in substance. PEMF therapy appears to be effective in the short term to relieve pain and improve function in patients with osteoarthritis. The existing studies used very heterogeneous treatment schemes, mostly with low sample sizes and suboptimal study designs, from which no sufficient proof of efficacy can be derived. The authors drew up a catalogue of measures to improve the quality of future studies.

Both halves of that conclusion are true simultaneously, and quoting only the first half is how this paper gets misused.

Why this research matters

Osteoarthritis pain is the application most likely to motivate someone to buy PEMF equipment for themselves rather than for an athlete's recovery routine.

The review also demonstrates something useful about evidence generally: reviews of the same literature disagreeing is a signal that the underlying studies are too heterogeneous and too small to settle the question.

Study design

Study type
Systematic review of systematic reviews (umbrella review)
Databases searched
PubMed, Embase, PEDro, Web of Science
Protocol
Predetermined
Studies identified
69
Reviews included in final analysis
10
Joints covered
All 10 covered knee OA; 4 also cervical, 2 hand, 1 ankle
Population
Patients with diagnosed osteoarthritis
Intervention
Pulsed electromagnetic field therapy
Outcomes
Pain, stiffness, physical function
Quality of included reviews
Most of low or medium quality
Treatment schemes
Very heterogeneous across the underlying studies
Sample sizes
Mostly low
Device parameters
Not reported in the source abstract

What the researchers found

Sixty-nine studies were identified and ten systematic reviews were included in the final analysis.

All ten focused on knee osteoarthritis; four also reported on cervical, two on hand and one on ankle osteoarthritis.

Most included studies were of low or medium quality in terms of level of evidence and bias.

Most concurrence between reviews was observed for pain reduction. Endpoints such as stiffness and physical function showed greater variability in outcomes.

The authors conclude PEMF appears effective in the short term to relieve pain and improve function, while stating that the heterogeneous treatment schemes, low sample sizes and suboptimal study designs mean no sufficient proof of efficacy can be derived. No pooled effect estimates are generated and none are reproduced here.

What the results mean

The most defensible reading is that PEMF may help short-term osteoarthritis pain, and that the evidence is not good enough to be confident about it.

Agreement between reviews on pain is meaningful - independent groups looking at overlapping evidence reached similar conclusions on that endpoint. Disagreement on stiffness and function suggests those effects, if present, are smaller or less consistent.

The phrase 'no sufficient proof of efficacy can be derived' is the authors' own, and it is the sentence that should accompany any citation of this paper. Short-term pain relief in a supervised clinical setting is also a narrower claim than general wellbeing, which is what consumer equipment is sold for.

What this study does not prove

  • It does not establish efficacy. The authors state explicitly that no sufficient proof of efficacy can be derived from the existing studies.
  • It does not address long-term outcomes; the reported effect is short-term.
  • It does not apply to consumer wellness mats. The underlying studies used clinical PEMF therapy for diagnosed osteoarthritis.
  • It does not establish an effective treatment protocol; schemes were very heterogeneous.
  • It does not support claims for sleep, energy, recovery, or general wellbeing.
  • It does not establish that PEMF modifies the underlying disease, only that pain may be reduced in the short term.

Evidence strength

Systematic review of systematic reviews (umbrella review)

An umbrella review synthesises existing systematic reviews rather than primary studies. It is the appropriate design when a field already has multiple reviews reaching different conclusions, because it exposes where they agree and disagree.

Its ceiling is set by those reviews. Here, most were assessed as low or medium quality, which limits how much confidence the synthesis can carry however carefully it was conducted.

Strengths and limitations

Strengths

  • Umbrella design appropriate to a field with multiple conflicting reviews.
  • Predetermined protocol and four databases searched.
  • Assesses the quality and bias of the included reviews rather than accepting their conclusions.
  • Distinguishes between endpoints with concurrence and endpoints with variability.
  • States the limits of the evidence in unusually plain language.
  • Produces a constructive catalogue of measures to improve future study quality.

Limitations

  • Most included reviews were of low or medium quality.
  • Very heterogeneous treatment schemes across the underlying primary studies.
  • Low sample sizes in the underlying studies.
  • Suboptimal study designs acknowledged throughout.
  • Overlap between primary studies across the ten reviews is not reported in the source abstract, so the same trials may be counted repeatedly.
  • Device parameters not reported.
  • Predominantly knee osteoarthritis, limiting generalisability to other joints.

Does this apply to the equipment IMPERVITA sells?

The underlying studies used clinical PEMF therapy delivered for diagnosed osteoarthritis. This does not transfer to a consumer wellness mat bought without a diagnosis.

The distinction is regulatory as well as clinical. A device marketed to relieve osteoarthritis pain is making a disease claim and would fall under the medical device pathway. A wellness mat marketed for general wellbeing sits outside it, and has not been required to demonstrate anything comparable.

Anyone with osteoarthritis considering PEMF should discuss it with a clinician rather than buying a wellness product on the strength of this literature.

Evidence in context

This review is consistent with the broader pattern in the PEMF field. The 2020 meta-analysis on fracture healing reported moderate-quality evidence for healing rate and pain, while the 2024 systematic review update found no significant effect on acute bone healing.

Across all three, the recurring problems are identical: heterogeneous device parameters, small samples, and suboptimal designs. The authors of every one of them call for standardised parameters and better trials.

No large, well-powered, parameter-standardised trial has been published in any PEMF application as far as we are aware.

Related research

  1. Effectiveness of pulsed electromagnetic fields on bone healing: a systematic review and meta-analysis of randomized controlled trials Peng L, Fu C, Xiong F, et al. Bioelectromagnetics 41(5):323-337. 2020. PMID 32495506; doi:10.1002/bem.22271.The fracture-healing meta-analysis with the most favourable findings in this field.
  2. Effects of pulsed electromagnetic fields on bone fractures: a systematic review update Picelli A, Di Censo R, Tomasello S, et al. European Journal of Physical and Rehabilitation Medicine 60(6):989-994. 2024. PMID 39387850; PMC11729704; doi:10.23736/S1973-9087.24.08226-1.The 2024 update that found no significant effect on acute fracture healing.
  3. General wellness: policy for low risk devices - guidance for industry and FDA staff U.S. FDA, Center for Devices and Radiological Health. Docket FDA-2014-N-1039. 2019. CDRH guidance.FDA guidance on the general wellness boundary, which determines what a consumer mat may claim.
  4. Health products compliance guidance U.S. Federal Trade Commission, Bureau of Consumer Protection. 2022. Replaces the 1998 Dietary Supplements advertising guide.FTC substantiation standard for advertising health claims.

Practical buyer relevance

If osteoarthritis pain is your reason for looking at PEMF, this is the most relevant entry in the library - and it says the evidence is suggestive rather than sufficient.

Practically, that argues for two things. Speak to a clinician about it rather than self-treating a diagnosed condition with a wellness product. And if you do buy, buy on specifications you can verify - field intensity with a stated measurement point, frequency range, waveform, and the actual settings behind named programmes - rather than on outcome claims the evidence does not sustain.

Be particularly wary of any consumer device whose marketing cites osteoarthritis research. That is a disease claim attached to a product that has not been through the pathway required to make one.

Safety context

Pulsed electromagnetic fields can interact with implanted electronic devices. Equipment must not be used by anyone with a pacemaker, implanted defibrillator, insulin pump, cochlear implant or other active implant, and manufacturer contraindication lists should be read before purchase rather than after delivery.

People who are pregnant, have epilepsy, or have an active malignancy may require guidance from a qualified healthcare professional before use. The trials underlying the evidence in this category were conducted under clinical supervision for diagnosed conditions, which is a different context from unsupervised general wellness use.

Full source record

Title
Effects of Pulsed Electromagnetic Field Therapy on Outcomes Associated With Osteoarthritis: A Systematic Review of Systematic Reviews
Authors
Markovic L, Wagner B, Crevenna R
Organization
Medical University of Vienna
Publication
Wiener klinische Wochenschrift
Year
2022
Volume / issue / pages
Volume 134, issue 11-12, pages 425-433
Study type
Systematic review of systematic reviews (umbrella review)
Sample size
10 systematic reviews included from 69 identified
Population
Patients with osteoarthritis - all included reviews covered knee OA; four also cervical, two hand, one ankle
Topic
PEMF, Recovery
Document type
Systematic review
Technology context
Clinical PEMF therapy for diagnosed osteoarthritis, predominantly of the knee
Related equipment context
PEMF
Source last verified
19 August 2026

References

  1. Effects of pulsed electromagnetic field therapy on outcomes associated with osteoarthritis: a systematic review of systematic reviews Markovic L, Wagner B, Crevenna R. Wiener klinische Wochenschrift 134(11-12):425-433. 2022. PMID 35362792; PMC9213303; doi:10.1007/s00508-022-02020-3.
  2. Effectiveness of pulsed electromagnetic fields on bone healing: a systematic review and meta-analysis of randomized controlled trials Peng L, Fu C, Xiong F, et al. Bioelectromagnetics 41(5):323-337. 2020. PMID 32495506; doi:10.1002/bem.22271.
  3. Effects of pulsed electromagnetic fields on bone fractures: a systematic review update Picelli A, Di Censo R, Tomasello S, et al. European Journal of Physical and Rehabilitation Medicine 60(6):989-994. 2024. PMID 39387850; PMC11729704; doi:10.23736/S1973-9087.24.08226-1.
  4. General wellness: policy for low risk devices - guidance for industry and FDA staff U.S. FDA, Center for Devices and Radiological Health. Docket FDA-2014-N-1039. 2019. CDRH guidance.
  5. Health products compliance guidance U.S. Federal Trade Commission, Bureau of Consumer Protection. 2022. Replaces the 1998 Dietary Supplements advertising guide.

Information provided by IMPERVITA is for educational and general wellness purposes and is not intended to replace professional medical advice, diagnosis, or treatment.

Scroll to Top